Additionally, in animal studies using heterotopic or orthotopic xenograft models or transgenic mouse models for bladder cancer, surgical or medical castration, as well as treatment with anti-AR agents, impaired the growth of tumors [8,30,63–65]. This evidence concerns the gene AR and urinary bladder carcinoma.